215 related articles for article (PubMed ID: 32014599)
1. Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles.
Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Erol K; Demirel M
Int J Pharm; 2020 Mar; 578():119106. PubMed ID: 32014599
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles.
Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Vural İ; Demirel M
Drug Dev Ind Pharm; 2019 Oct; 45(10):1635-1645. PubMed ID: 31342792
[No Abstract] [Full Text] [Related]
3. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
5. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
[TBL] [Abstract][Full Text] [Related]
6. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
7. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
8. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
Gabr MM; Mortada SM; Sallam MA
J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
[TBL] [Abstract][Full Text] [Related]
9. Preparation and
Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
13. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.
Garg A; Bhalala K; Tomar DS; Wahajuddin
Int J Pharm; 2017 Jan; 516(1-2):120-130. PubMed ID: 27989820
[TBL] [Abstract][Full Text] [Related]
14. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies.
Patel M; Mundada V; Sawant K
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):144-153. PubMed ID: 30669881
[TBL] [Abstract][Full Text] [Related]
15. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
16. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
17. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
18. Improved uptake and bioavailability of cinnamaldehyde
Wu L; Meng Y; Xu Y; Chu X
Pharm Dev Technol; 2022 Dec; 27(10):1038-1048. PubMed ID: 36367964
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of lipid levels in triton induced hyperlipidemia rats through rosuvastatin calcium nanoparticles: Pharmacokinetic and pharmacodynamic studies.
Dudhipala NR; Ettireddy SR; Puchakayala GR
Chem Phys Lipids; 2021 Jul; 237():105081. PubMed ID: 33811848
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation.
Rehman MU; Khan MA; Khan WS; Shafique M; Khan M
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1926-1934. PubMed ID: 29113501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
